Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Solomon

Dermatology North Las Vegas, NV Medical Doctor

NPI 1023128345 CMS profile 91550

6900 N Pecos Rd, North Las Vegas, NV 89086

Open in the dashboard

General payments

$14,293

89 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$718,219 paid to institutions, not to them · program years 2019–2023

Through program year 2025, James Solomon of North Las Vegas, NV is reported in the CMS Open Payments database as having received $14,293 across 89 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $718,219 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 85th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $125 1
2024 General $277 4
2023 General $134 4
2022 General $429 18
2021 General $4,448 21
2020 General $2,518 15
2019 General $6,362 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Solomon
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to James Solomon were reported at $125. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year James Solomon Dermatology median Middle half National median
2019 $6,362 $454 $129–$1,240 $163
2020 $2,518 $235 $81–$756 $114
2021 $4,448 $377 $108–$1,108 $132
2022 $429 $514 $143–$1,391 $149
2023 $134 $607 $159–$1,674 $160
2024 $277 $751 $204–$1,903 $164
2025 $125 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. LEO Pharma AS $4,334 2 payments
  2. Sun Pharmaceutical Industries Inc. $4,214 5 payments
  3. Pfizer Inc. $3,540 15 payments
  4. E.R. Squibb & Sons, L.L.C. $353 7 payments
  5. AbbVie, Inc. $241 8 payments
  6. Genentech USA, Inc. $236 9 payments
  7. Novartis Pharmaceuticals Corporation $231 15 payments
  8. Incyte Corporation $209 3 payments
  9. Genzyme Corporation $174 3 payments
  10. UCB, Inc. $146 3 payments
  11. Other $615 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $4,334 2 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,149 2 payments
  3. Food and Beverage $3,392 79 payments
  4. Travel and Lodging $2,403 5 payments
  5. Education $15 1 payment
Products named General payments · program years 2019–2025
  1. ODOMZO $4,149 2 payments
  2. SOTYKTU $250 6 payments
  3. Erivedge $220 8 payments
  4. DUPIXENT $174 3 payments
  5. HUMIRA $152 4 payments
  6. VTAMA $140 1 payment
  7. BOTOX COSMETIC $123 1 payment
  8. EUCRISA $119 7 payments
  9. COSENTYX Immunology $111 8 payments
  10. COSENTYX Dermatology $91 5 payments
  11. Other $670 34 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

89 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record